leflunomide has been researched along with Canine Diseases in 5 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Excerpt | Relevance | Reference |
---|---|---|
"To evaluate efficacy and adverse effects of leflunomide for the treatment of naturally occurring immune-mediated polyarthritis (IMPA) in dogs." | 7.76 | Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008). ( Baker, TA; Colopy, SA; Muir, P, 2010) |
"To evaluate efficacy and adverse effects of leflunomide for the treatment of naturally occurring immune-mediated polyarthritis (IMPA) in dogs." | 3.76 | Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008). ( Baker, TA; Colopy, SA; Muir, P, 2010) |
" Data that were extracted from the medical records included signalment, body weight, underlying indication for leflunomide, dosage of leflunomide, treatment duration, concurrent medications, treatment response, and adverse events." | 1.46 | A Retrospective Study on the Safety and Efficacy of Leflunomide in Dogs. ( Lappin, MR; Legare, M; Sato, M; Veir, JK, 2017) |
"The leflunomide treatment response rate was 93." | 1.43 | Efficacy of leflunomide for treatment of refractory inflammatory colorectal polyps in 15 Miniature Dachshunds. ( Eguchi, N; Fukushima, K; Igarashi, H; Kanemoto, H; Nakashima, K; Ohmi, A; Ohno, K; Takahashi, M; Tsujimoto, H, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Tani, A | 1 |
Seno, T | 1 |
Yokoyama, N | 1 |
Nakagawa, T | 1 |
Tomiyasu, H | 1 |
Goto-Koshino, Y | 1 |
Tsujimoto, H | 2 |
Ohno, K | 2 |
Sato, M | 1 |
Veir, JK | 1 |
Legare, M | 1 |
Lappin, MR | 1 |
Fukushima, K | 1 |
Eguchi, N | 1 |
Kanemoto, H | 1 |
Takahashi, M | 1 |
Igarashi, H | 1 |
Ohmi, A | 1 |
Nakashima, K | 1 |
Colopy, SA | 1 |
Baker, TA | 1 |
Muir, P | 1 |
Gregory, CR | 1 |
Stewart, A | 1 |
Sturges, B | 1 |
DeManvelle, T | 1 |
Cannon, A | 1 |
Ortega, T | 1 |
Harb, M | 1 |
Morris, RE | 1 |
5 other studies available for leflunomide and Canine Diseases
Article | Year |
---|---|
Comparison of the efficacy of cyclosporine and leflunomide in treating inflammatory colorectal polyps in miniature dachshunds.
Topics: Animals; Colonic Polyps; Cyclosporine; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Japan; | 2020 |
A Retrospective Study on the Safety and Efficacy of Leflunomide in Dogs.
Topics: Animals; Dog Diseases; Dogs; Female; Immune System Diseases; Immunosuppressive Agents; Isoxazoles; L | 2017 |
Efficacy of leflunomide for treatment of refractory inflammatory colorectal polyps in 15 Miniature Dachshunds.
Topics: Animals; Colonic Polyps; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Intestinal Polyps; Is | 2016 |
Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Autoimmune Diseases; Dog Diseases; Dogs | 2010 |
Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy.
Topics: Aniline Compounds; Animals; Crotonates; Dog Diseases; Dogs; Female; Hydroxybutyrates; Immune System | 1998 |